1. Zarbl,H., Latreille,J. and Jolicoeur,P. ( 1987 ) Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell , 51 , 357 –369.
2. Boylan,M.O., Athanassiou,M., Houle,B., Wang,Y. and Zarbl,H. ( 1996 ) Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line. Cell Growth Differen. , 7 , 725 –735.
3. Athanassiou,M., Hu,Y., Jing,L., Houle,B., Zarbl,H. and Mikheev,A.M. ( 1999 ) Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells. Cell Growth Differen. , 10 , 729 –737.
4. Summerhayes,I.C., Lampidis,T.J., Bernal,S.D., Nadakavukaren,J.J., Nadakavukaren,K.K., Shepherd,E.L. and Chen,L.B. ( 1982 ) Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl Acad. Sci. USA , 79 , 5292 –5296.
5. Latham,K.M. and Stanbridge,E.J. ( 1992 ) Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa × fibroblast cell hybrids. Cancer Res. , 52 , 616 –622.